Table of Contents
UPCOMING PATENT EXPIRES BY THERAPY AREA
Hypercholesterolemia Pipeline
Overview
--% of Projects (By Phase of Development)
--No. of Projects
by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline
Projects
--Top Companies in late stage Hypercholesterolemia
Projects
--Aurobindo Pharma Ltd.
--Aegerion Pharmaceuticals, Inc.
--Genzyme Corporation
--Forbes Medi-Tech Inc
--Kowa Company, Ltd.
--Isis Pharmaceuticals Inc
--Microbia
--Merck & Co Inc
--RECORDATI
SpA
--Nissan Chemical Industries, Ltd.
--Schering-Plough Corp
--Sanofi-Aventis
--Takeda Pharmaceutical Company Limited
--SCOLR
Pharma Inc
--Top Companies in early stage Hypercholesterolemia
Projects
--Ardana plc
--Alnylam Pharmaceuticals Inc
--Cerenis
Therapeutics SA
--AVI BioPharma Inc
--GalMed Medical Research Ltd.
--Forbes Medi-Tech Inc
--Nisshin Seifun Group
--MaxoCore
Pharmaceuticals Inc
--Samaritan Pharmaceuticals Inc
--REPLICor
Inc.
--SCOLR Pharma Inc
--Sanofi-Aventis
Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval
Pipeline View
--Approved Pipeline View
--On the Market Pipeline
View
--Discovery/Development Pipeline View